These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11835103)

  • 1. Human Pharmacokinetics of the Neuroprotective Agent NBQX.
    Ingwersen SH; Ohrström JK; Petersen P; Drustrup J; Bruno L; Nordholm L
    Am J Ther; 1994 Dec; 1(4):296-303. PubMed ID: 11835103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Gender and Menopausal Status on the Pharmacokinetics of Tirilazad Mesylate in Healthy Subjects.
    Fleishaker JC; Hulst-Pearson LK; Peters GR
    Am J Ther; 1995 Aug; 2(8):553-560. PubMed ID: 11854826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple-Dose Pharmacokinetics of Ceftibuten in Healthy Adults and Geriatric Volunteers.
    Radwanski E; Teal M; Affrime M; Cayen M; Lin CC
    Am J Ther; 1994 Jun; 1(1):42-48. PubMed ID: 11835066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics in Non-Insulin-Dependent Diabetics of the Aldose Reductase Inhibitor, Zopolrestat.
    Inskeep PB; Reed AE; Connolly AG; Wilner KD; Vargas R; McMahon FG
    Am J Ther; 1995 Feb; 2(2):112-118. PubMed ID: 11847537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misoprostol and Prednisone Treatment of Lupus Nephritis.
    Belmont HM; Kitsis E; Skovron ML; Buyon J; McCullagh E; Abramson S
    Am J Ther; 1995 Dec; 2(12):928-932. PubMed ID: 11854810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Food on the Pharmacokinetics and Pharmacodynamics of Torsemide.
    Kramer WG
    Am J Ther; 1995 Jul; 2(7):499-503. PubMed ID: 11850698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single- and Multiple-Dose Pharmacokinetics of Reduced Metabolite (MDL 74,156) following Oral Administration of Dolasetron Mesylate to Normal Male Subjects.
    Shah A; Lanman R; Bhargava V; Weir S; Hahne W
    Am J Ther; 1996 May; 3(5):364-370. PubMed ID: 11862273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobramycin Serum Concentrations After Aerosol and Oral Administration in Cystic Fibrosis.
    Weber A; Williams-Warren J; Ramsey B; Smith AL
    Am J Ther; 1995 Feb; 2(2):81-87. PubMed ID: 11847533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Pharmacokinetics and Pharmacodynamics of Methylprednisolone in Chronic Renal Failure.
    Milad MA; Ludwig EA; Lew KH; Kohli RK; Jusko WJ
    Am J Ther; 1994 Jun; 1(1):49-57. PubMed ID: 11835067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Nonparametric Alternative to Modeling Population Pharmacokinetics in Patients with Spinal Cord Injury: Comparison with the Standard Two-Stage Method.
    Segal JL; Gilman TM; Brunnemann SR
    Am J Ther; 1995 Feb; 2(2):100-105. PubMed ID: 11847535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose--Response Study of Colestipol Tablets in Patients with Moderate Hypercholesterolemia.
    Hunninghake DB; Stein EA; Bremner WF; Greenland P; Demke DM; Oliphant TH
    Am J Ther; 1995 Mar; 2(3):180-189. PubMed ID: 11847550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and Pharmacodynamics of Recombinant Human Insulin-Like Growth Factor.
    Morgan JM; Piraino AJ; Hirschhorn WL; Capuzzi DM
    Am J Ther; 1995 May; 2(5):320-327. PubMed ID: 11850670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption.
    Pace S; Longo A; Toon S; Rolan P; Evans AM
    Br J Clin Pharmacol; 2000 Nov; 50(5):441-8. PubMed ID: 11069438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancy between Bioavailability and Hypotensive Effect of Oral and Sublingual Nifedipine.
    Palma-Aguirre JA; Montoya-Cabrera MA; du Souich P; Hoyo-Vadillo C; Flores-Murrieta FJ; Castañeda-Hernández G
    Am J Ther; 1995 Jan; 2(1):3-9. PubMed ID: 11850640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of Pharmacokinetic Interaction between Aspirin and Warfarin.
    Fiske WD; Connell JM; Benedek IH
    Am J Ther; 1995 Jun; 2(6):407-413. PubMed ID: 11850685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and Safety of a Potential Antidementia Compound, CL 275,838, after Multiple Oral Doses in Patients with Dementia of Alzheimer Type or Vascular Dementia.
    Caccia S; Confalonieri S; Guiso G; Lucca U; Tettamanti M; Tiraboschi P; Spagnoli A
    Am J Ther; 1995 Jan; 2(1):61-67. PubMed ID: 11850650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Lansoprazole on the Disposition of Antipyrine and Indocyanine Green in Normal Human Subjects.
    St Peter JV; Awni WM; Granneman GR; Karol MD
    Am J Ther; 1995 Aug; 2(8):561-568. PubMed ID: 11854827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early clinical experience with the novel NMDA receptor antagonist CNS 5161.
    Walters MR; Bradford AP; Fischer J; Lees KR
    Br J Clin Pharmacol; 2002 Mar; 53(3):305-11. PubMed ID: 11874394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of the neuroprotective glutamate antagonist NBQX (6-nitro-7-sulfamoyl-benzo(f)quinoxaline-2,3-dione) in mice, rats, and dogs. Interactions with probenecid.
    Dalgaard L; Hjortkjaer RK; Regnier B; Nordholm L
    Drug Metab Dispos; 1994; 22(2):289-93. PubMed ID: 7912178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.